Form 4 for BCRX BIOCRYST PHARMACEUTICALS INC
Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001127602-22-008047 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-03 | 2022-03-01 | BCRX | Jones Michael L | Exec. Dir, Fin - PAO | S - Sale+OE | $17.20 | -2,300 | 11.2K | -17% | -$39.6K |
| D | 2022-03-03 | 2022-03-01 | BCRX | Jones Michael L | Exec. Dir, Fin - PAO | M - OptEx | $4.73 | +2,300 | 13.5K | +21% | +$10.9K |
| D | 2022-03-03 | 2022-03-01 | BCRX | Jones Michael L | Exec. Dir, Fin - PAO | M - OptEx | $0.00 | -2,300 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-01 | S | D | 2,300 | $17.20 | 11,198 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-01 | M | A | 2,300 | $4.73 | 13,498 | D | — | — | |
| 3 | Derivative | Emp. Stock Option (Right to Buy) | 2022-03-01 | M | D | 2,300 | $0.00 | 0 | D | $4.73 · 2013-03-01 to 2022-03-01 | 2,300 Common Stock |